2nd Quarter - Amendment
DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC
Income
—
Expenses
$48,750
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Sep 21, 2020 | $48,750 | Replaced |
| 2nd Quarter - Amendment (this page) | Sep 21, 2020 | $48,750 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Access to prostate cancer immunotherapy at the Veterans Health Administration
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NANJING XINJIEKOU DEPARTMENT STORE, CO. LTD. | China | China | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.